Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01560923 |
| Title | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Masonic Cancer Center, University of Minnesota |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Illinois Medical Center | Chicago | Illinois | 60612 | United States | Details | |
| Masonic Cancer Center, University of Minnesota | Minneapolis | Minnesota | 55455 | United States | Details | |
| New York Presbyterian/Weill Cornell Medical Center | New York | New York | 10065 | United States | Details | |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | United States | Details |